Evidence mapPaperPMID 39377129Full record

ArticleDiabetes, obesity & metabolism2025

Relationship of high-density lipoprotein subfractions and apolipoprotein A-I with fat in the pancreas.

Yutong Liu, Xiatiguli Shamaitijiang, Loren Skudder-Hill, Wandia Kimita, Ivana R Sequeira-Bisson, Maxim S Petrov

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Relationship of fat in the pancreas with cardiovascular disease: A systematic review and meta-analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yutong LiuSchool of Medicine, University of Auckland, Auckland, New Zealand.
Xiatiguli ShamaitijiangSchool of Medicine, University of Auckland, Auckland, New Zealand.
Loren Skudder-HillSchool of Medicine, University of Auckland, Auckland, New Zealand.
Wandia KimitaSchool of Medicine, University of Auckland, Auckland, New Zealand.
Ivana R Sequeira-BissonHuman Nutrition Unit, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Maxim S PetrovSchool of Medicine, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-5923-9062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the associations of high-density lipoprotein (HDL) subfractions and apolipoprotein A-I (apo A-I) with fat in the pancreas.

methodsA total of 170 individuals were studied. All participants underwent magnetic resonance imaging on a single 3.0-Tesla scanner to determine the presence/absence of fatty pancreas. HDL subfractions were measured using a commercially available lipoprotein subfractions testing system and classed as large, intermediate and small HDL. Both unadjusted and adjusted (accounting for demographics, anthropometrics, insulin resistance and other covariates) logistic regression models were built.

resultsIndividuals with fatty pancreas had significantly lower circulating levels of the large HDL class and apo A-I. Every unit decrease in the large HDL class was associated with a 93% increase in the likelihood of fatty pancreas in the most adjusted model (P < .001). Every unit decrease in apo A-I was associated with a 45% increase in the likelihood of fatty pancreas in the most adjusted model (P = .012). The intermediate and small HDL classes were not significantly associated with fatty pancreas.

conclusionsFat in the pancreas is inversely associated with the circulating levels of large HDL particles and apo A-I. Purposely designed studies are warranted to investigate the potential of fatty pancreas as an indicator of the risk of cardiovascular diseases.

Indexed as

Apolipoprotein A-ILipoproteins, HDLPancreasAdultAgedFemaleHumansInsulin ResistanceMagnetic Resonance ImagingMaleMiddle AgedPancreatic DiseasesApolipoprotein A-ILipoproteins, HDLapolipoprotein A‐Ibody compositionHDL cholesterolintrapancreatic fatpancreas

Identifiers

PMID39377129
PMCPMC11618224

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.